Journey Medical Corporation
DERM
$6.07
-$0.11-1.78%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 64.02M | 61.24M | 57.79M | 55.40M | 55.24M |
| Total Other Revenue | 659.00K | 619.00K | 1.61M | 1.00M | 1.00M |
| Total Revenue | 64.68M | 61.86M | 59.40M | 56.40M | 56.24M |
| Cost of Revenue | 22.35M | 20.92M | 20.16M | 18.88M | 19.67M |
| Gross Profit | 42.33M | 40.93M | 39.24M | 37.52M | 36.58M |
| SG&A Expenses | 43.91M | 44.37M | 44.57M | 43.91M | 42.35M |
| Depreciation & Amortization | 4.32M | 4.26M | 4.17M | 3.92M | 3.67M |
| Other Operating Expenses | -- | -- | -4.55M | -4.55M | -4.55M |
| Total Operating Expenses | 71.02M | 70.03M | 64.89M | 63.26M | 63.15M |
| Operating Income | -6.34M | -8.17M | -5.50M | -6.86M | -6.91M |
| Income Before Tax | -9.53M | -11.37M | -8.54M | -8.62M | -8.24M |
| Income Tax Expenses | 60.00K | 60.00K | 121.00K | 121.00K | 61.00K |
| Earnings from Continuing Operations | -9.59 | -11.43 | -8.66 | -8.74 | -8.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.59M | -11.43M | -8.66M | -8.74M | -8.30M |
| EBIT | -6.34M | -8.17M | -5.50M | -6.86M | -6.91M |
| EBITDA | -2.02M | -3.91M | -1.32M | -2.94M | -3.24M |
| EPS Basic | -0.38 | -0.48 | -0.36 | -0.39 | -0.39 |
| Normalized Basic EPS | -0.24 | -0.30 | -0.22 | -0.27 | -0.28 |
| EPS Diluted | -0.38 | -0.48 | -0.36 | -0.39 | -0.39 |
| Normalized Diluted EPS | -0.24 | -0.30 | -0.22 | -0.27 | -0.28 |
| Average Basic Shares Outstanding | 102.66M | 97.97M | 92.17M | 87.75M | 84.45M |
| Average Diluted Shares Outstanding | 102.66M | 97.97M | 92.17M | 87.75M | 84.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |